Thus, there is an unmet need for new inotropic strategies. This session will review the clinical need for new inotropic strategies, the basic science underpinning novel strategies for enhancing cardiac contractility, and emerging date from proof-of-concept pre-clinical clinical research. Target audience is primarily physician and non-physician practitioners who care for patients with severe or unstable heart failure syndromes. Additionally, this session will be of value for clinical trainees and scientists involved with early and late therapeutic drug development.
Clinical Chief of Cardiology,
UT Southwestern Medical Center, Dallas, TX